BioSpace

MARCH 17, 2021

Multiple pharmaceutical companies struck large licensing deals with one another this week. Here's a look.

Pharma Companies 58

Pharma Companies Licensing Licensing 58

pharmaphorum

APRIL 22, 2021

Biosensor firm physIQ has licensed its technology to Johnson & Johnson’s Janssen pharma unit in a multi-year deal, to investigate use of wearable sensors in virtual clinical trials. The pharma company will use the technology known as accelerateIQ to collect data across its clinical studies through a variety of wearable biosensors.

Licensing 70

Licensing Licensing Trials Clinical Trials 70

Pharmaceutical Technology

JUNE 19, 2023

Indian pharmaceutical company Laurus Labs has signed a memorandum of agreement (MoA) with the Indian Institute of Technology, Kanpur (IIT Kanpur) to bring new gene therapy products to the market. Laurus Labs will be responsible for launching these products in India and emerging markets.

Gene Therapy 246

Gene Therapy Gene Production Pharma Companies 246

Fossil Remedies

SEPTEMBER 23, 2022

PCD Pharma Franchise is a popular business model. It is a business arrangement in which a pharma company offers the rights of marketing and distribution to its franchise partner. The pharma company thus expands its business and reaches new regions. Check the market reputation and image of the company.

Pharma Companies 52

Pharma Companies Production Licensing Licensing 52

Fossil Remedies

JANUARY 19, 2022

Experts say that one should choose an ISO-certified company that works as per the standards and guidelines laid by WHO and GMP. The company should have a countrywide distribution network and a customer-oriented approach. The PCD pharma company you choose should have a good reputation and bright history.

Production 98

Production Pharma Companies Pharma Production Marketing 98

Pharmaceutical Technology

APRIL 17, 2023

Telix has announced the successful preclinical development of radiolabelled olaratumab, an antibody licensed by Eli Lilly and Company. If the Australian pharma company can demonstrate a renewed potential for the drug, Lilly could receive up to $255m in commercial and regulatory milestone payments.

Development 130

Development Antibody Pharma Companies Licensing 130

Drug Discovery World

FEBRUARY 23, 2023

Spanish pharma company Ferrer and Swiss biotech Asceneuron have signed a licensing agreement giving Ferrer the rights to ASN90 in progressive supranuclear palsy (PSP), an orphan, tau-related disease with a high unmet medical need.

Drugs 52

Drugs Licensing Licensing Protein 52

pharmaphorum

FEBRUARY 3, 2022

India’s Dr Reddy’s Laboratories has joined the growing list of pharma companies that are looking to tap into the market for medical cannabis, buying German developer Nimbus Health for an undisclosed sum.

Licensing 114

Licensing Licensing Marketing Medicine 114

pharmaphorum

JULY 14, 2022

The legacy product now lies outside Bayer’s core areas of cardiology, oncology, haematology, ophthalmology, women’s health and radiopharmaceuticals, and the funds raised from the sale will support the “ongoing transformation of Bayer’s pharma business to focus on key areas of future medical innovation”, said the company.

Drugs 84

Drugs Sales Pharma Companies Cardiology 84

Pharmaceutical Technology

SEPTEMBER 2, 2022

In a recent report, GlobalData revealed that the US Food and Drug Administration (FDA) approved 122 new drug applications (NDAs) and biologic license applications (BLAs) in 2021. There are many reasons why a company might prefer to keep commercialisation activities inhouse. The rate of drug approvals could be on the rise.

Drugs 130

Drugs Pharma Companies Sales Production 130

Drug Discovery World

FEBRUARY 5, 2024

However, two-thirds (68%) of patients are comfortable receiving medicines before they’re licensed through their country’s healthcare system. The new data was released by pharma company Clinigen to mark the start of Rare Disease Month.

Medicine 52

Medicine Pharma Companies Licensing Licensing 52

pharmaphorum

MAY 4, 2022

Once selected, Quris can in-license them, progress them through to phase 1 trials and, those that succeed, can be licensed to pharma companies. In this manner, Bentwich explained that Quris is able to profit from the higher rates that are paid for post-phase 1 drug candidates, with the value typically tripling.

Drugs 142

Drugs Licensing Licensing Pharma Companies 142

BioTech 365

OCTOBER 15, 2020

ISTANBUL–(BUSINESS WIRE)– Company name: Er-Kim Ilac Presentative: Cem Zorlular, CEO AnGes, Inc.,

Pharma Companies 40

Pharma Companies Licensing Licensing Gene 40

pharmaphorum

NOVEMBER 29, 2021

It was billed at the time as a key tool to accelerate the development of new and innovative vaccines to combat some of the world’s most prevalent diseases, from discovery to licensed product.

Vaccination 92

Vaccination Vaccine Manufacturing Pharma Companies 92

pharmaphorum

DECEMBER 6, 2022

$500 million upfront and a total deal value of up to $5 billion sounds like a deal made by a top-tier pharma company – but in fact it comes from diminutive biotech Summit Therapeutics. The post Little Summit Therapeutics spends big bucks to rebuild pipeline appeared first on.

Licensing 52

Licensing Licensing Antibody Clinical Trials 52

pharmaphorum

FEBRUARY 11, 2022

Ipsen has started exclusive negotiations that could see its global consumer health business sold to fellow French pharma company Mayoly Spindler later this year. billion of its revenues last year.

Sales 87

Sales Pharma Companies Branding Cosmetics 87

Fossil Remedies

AUGUST 21, 2019

It is an agreement between a franchiser which is typically a pharma manufacturing (or marketing) company where a franchisee is an individual entrepreneur or a small company that buys the license. Why is it a great idea to launch a pharma franchise? Drug license copy (wholesaler/retailer).

Pharma Companies 40

Pharma Companies Production Licensing Licensing 40

pharmaphorum

DECEMBER 22, 2021

Gyroscope Therapeutics and its gene therapy for the sight-robbing disease geographic atrophy (GA) has been acquired by a big pharma company – but likely not the one you would expect. Last year, it also signed a licensing deal with Dyno Therapeutics for its AAV capsid-based gene delivery technology focused on ocular diseases.

Gene Therapy 98

Gene Therapy Gene Licensing Licensing 98

pharmaphorum

MAY 20, 2022

In one of the first moves by a member of ATOM, Novartis has agreed to license rights to its tyrosine kinase inhibitor drug nilotinib – sold as Tasigna as a leukaemia treatment – to the UN-backed Medicines Patent Pool (MPP).

Drugs 106

Drugs Medicine Licensing Licensing 106

pharmaphorum

JANUARY 8, 2021

There’s a new player in the neurology and mental health drugs market after Italy’s Angelini Pharma merged with Switzerland’s Arvelle Therapeutics in a deal worth up to $960 million based around the anti-seizure drug cenobamate. Revenue share payments due to certain of the Arvelle shareholders will be assumed by Angelini Pharma.

Licensing 52

Licensing Licensing Pharma Companies Branding 52

pharmaphorum

JUNE 14, 2021

Rebecca Sanders from Lipodystrophy UK tells us how the patient voice helped convince NICE to approve a much-needed drug for this rare disease, and explores how regulators and pharma companies can help make patient involvement in HTA more impactful. The earlier HTAs, researchers and pharma companies can start that engagement the better.

Drugs 99

Drugs Pharma Companies Licensing Licensing 99

Creogenic Pharma

FEBRUARY 17, 2021

Franchise Company. When you are attempting to find the best PCD Pharma Company, you will run into a lot of them in the country. How To Select Best PCD Pharma Franchise Company. PCD PHARMA FRANCHISE. BEST PCD PHARMA COMPANY. Get Started with. Lowest Price. 250+ Products. Best Service.

Pharma Companies 52

Pharma Companies Production Doctors Doctor 52

pharmaphorum

SEPTEMBER 20, 2022

The big pharma company is making a $20 million investment in the Israeli startup along with funding that could reach $90 million over the next five years, in a return for options to license CytoReason’s AI platform and disease models.

Pharma Companies 52

Pharma Companies Trials Engineer Development 52

Pharmaceutical Technology

AUGUST 1, 2022

As a result, multiple vaccines, including Pfizer /BioNTech’s mRNA vaccine, Comirnaty, were licensed for use within a year of development beginning. If robust support comes from governments, pharma companies will grow in confidence about entering this area, and hopefully, a much-needed flurry of antibiotics will be developed.

Vaccination 234

Vaccination Vaccine Bacteria Life Science 234

World of DTC Marketing

APRIL 12, 2021

A blood-thinning agent, heparin, had been adulterated due to the product license holder (Baxter) procuring a toxic substance that had been illegally substituted for the genuine registered material. Why would a pharma company take risks like these? We can’t continue to develop drugs the same way as we have done before.

Generic Drugs 187

Generic Drugs Manufacturing Production Drugs 187

Camargo

NOVEMBER 11, 2020

Unpacking the (Black) Box: Antares Licenses Urology Product with Boxed Warning. In October, Antares Pharma licensed Ferring Pharmaceuticals’ Nocdurna® (desmopressin acetate) sublingual tablet , which was approved in 2018 for the same indication as Noctiva and has a boxed warning highlighting the same risks.

Development 242

Development Bioequivalency Generic Drugs Production 242

pharmaphorum

APRIL 22, 2021

Although the company has no agreements in place to acquire any companies, or license in any drugs, Centessa is interested in exploring such opportunities if they arise. The money could also be used for further acquisitions as well as for working capital and general corporate purposes.

Licensing 53

Licensing Licensing Pharma Companies Drugs 53

pharmaphorum

JUNE 4, 2021

The technology behind the drug was licensed from Weill Cornell Medicine and Johns Hopkins University in the US. ” The deal – financial terms of which were not disclosed – comes against a backdrop of increasing interest in radionuclide drugs among pharma companies.

Antibody 59

Antibody Licensing Licensing Protein 59

pharmaphorum

FEBRUARY 13, 2022

If all goes to plan, Merck has the option to obtain up to a five-year exclusive license to use of BioAI in a specific disease domain, which would result in an undisclosed payment to the Israeli startup. “If successful, this could lead to a much-needed transformation in drug development speed, safety and cost,” said Ciechanover.

Drugs 98

Drugs In-Vivo In-Vitro Pharma Companies 98

XTalks

FEBRUARY 15, 2024

US Senator Bernie Sanders, who chairs the Health, Education, Labor, and Pensions (HELP) Committee, managed to bring CEOs of major American pharma companies to a committee hearing to discuss exorbitant US drug pricing.

Drugs 52

Drugs Pharma Companies Pharmacy Regulation 52

pharmaphorum

APRIL 21, 2022

One of the leading companies in the bid to bring a new class of alpha-synuclein targeting drugs to market for Parkinson’s disease – AbbVie – is ducking out of the challenge. Interest in the target has also prompted a flurry of licensing deals. AZ/Takeda are meanwhile running phase 2 trials of their MEDI 1342 antibody candidate.

Antibody 85

Antibody Protein Gene Therapy Pharma Companies 85

pharmaphorum

JANUARY 6, 2022

The latest pharma company to make a move for an mRNA specialist is Germany’s Merck KGaA, which has offered a $780 million cash buyout to US biotech Exelead. Exelead was part of that success, helping to manufacture vaccine precursors for the Pfizer/BioNTech shot Comirnaty.

Vaccination 95

Vaccination Vaccine Manufacturing Life Science 95

pharmaphorum

DECEMBER 21, 2021

Novartis has joined the ranks of big pharma companies developing TIGIT-targeted drugs for cancer, and found its candidate in an existing partner, Chinese biotech BeiGene. Pharma companies are looking at whether blocking TIGIT as well as PD-1/PD-L1 can improve the efficacy of cancer immunotherapy.

Drugs 92

Drugs Antibody Pharma Companies Development 92

pharmaphorum

SEPTEMBER 22, 2021

Amnesty International has slammed the six pharma companies behind the bulk of COVID-19 vaccine supplies of for not agreeing to waive their intellectual property rights and share the technology behind them. billion doses administered worldwide, just 0.3%

Vaccination 103

Vaccination Vaccine Manufacturing Licensing 103

pharmaphorum

JANUARY 7, 2022

If the last couple of days is an indication, 2022 is already shaping up to be the year of big-ticket alliances between big pharma companies and specialists in artificial intelligence-driven discovery. Shortly after Amgen unveiled its $1.9

Drugs 98

Drugs Pharma Companies Medicine Licensing 98

pharmaphorum

OCTOBER 7, 2021

The factory will be able to supply up to 500 million doses of mRNA shots a year, and cover the full spectrum of manufacturing from drug substance production through to full/finish and packaging, according to the company. According to the latest WHO data, just 4.4%

Vaccination 90

Vaccination Vaccine Manufacturing Packaging 90

pharmaphorum

OCTOBER 28, 2020

Identifying, recruiting, retaining and monitoring patients during this part of the cycle is estimated to cost pharma US$19 billion a year as companies seek to harvest patient experiences. Once a drug is licensed and launched, however, there is a deafening silence. 72% do not feel listened to by pharmaceutical companies.

Medicine 117

Medicine Pharma Companies Vaccination Vaccine 117